Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rainer Soyka is active.

Publication


Featured researches published by Rainer Soyka.


Angewandte Chemie | 2001

Electronic Insight into an Antithrombotic Agent by High‐Resolution X‐Ray Crystallography

Ralf Flaig; Tibor Koritsanszky; Rainer Soyka; Ludger Häming; Peter Luger

Five instead of 200 days measurement time are sufficient (thanks to area detection rather than conventional scintillation detection) to obtain the accurate charge density distribution of an antithrombotic agent with more than 50 atoms by a high-resolution X-ray diffraction experiment. The preferred sites of intermolecular interactions were identified from various topological properties, such as the reactive surface (zero Laplacian function, see picture) and the electrostatic potential.


Organic Letters | 2014

Facile entry to an efficient and practical enantioselective synthesis of a polycyclic cholesteryl ester transfer protein inhibitor.

Zhengxu S. Han; Yibo Xu; Daniel R. Fandrick; Sonia Rodriguez; Zhibin Li; Bo Qu; Nina C. Gonnella; Sanjit Sanyal; Jonathan T. Reeves; Shengli Ma; Nelu Grinberg; Nizar Haddad; Dhileep Krishnamurthy; Jinhua J. Song; Nathan K. Yee; Waldemar Pfrengle; Markus Ostermeier; Jürgen Schnaubelt; Zeno A. Leuter; Sonja Steigmiller; Jürgen Däubler; Emanuel Stehle; Lukas Neumann; Thomas Trieselmann; Patrick Tielmann; Annette Buba; Rainer Hamm; Gunter Koch; Svenja Renner; Juan R. Dehli

An efficient enantioselective synthesis of the chiral polycyclic cholesteryl ester transfer protein (CETP) inhibitor 1 has been developed. The synthesis was rendered practical for large scale via the development of a modified Hantzsch-type reaction to prepare the sterically hindered pyridine ring, enantioselective hydrogenation of hindered ketone 6 utilizing novel BIBOP-amino-pyridine derived Ru complex, efficient ICl promoted lactone formation, and a BF3 mediated hydrogenation process for diastereoselective lactol reduction. This efficient route was successfully scaled to produce multikilogram quantities of challenging CETP drug candidate 1.


Archive | 2006

Process for preparing amino crotonyl compounds

Rainer Soyka; Werner Rall; Juergen Schnaubelt; Peter Sieger; Christian Kulinna


Archive | 1998

Substituted indoles, having a thrombin inhibiting effect

Armin Heckel; Rainer Walter; Rainer Soyka; Jean-Marie Stassen; Wolfgang Wienen; Klaus Binder


Journal of Medicinal Chemistry | 1999

Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors.

Rainer Soyka; Brian D. Guth; Hans Weisenberger; Peter Luger; Thomas Müller


Journal of Medicinal Chemistry | 1994

6,6-Disubstituted hex-5-enoic acid derivatives as combined thromboxane A2 receptor antagonists and synthetase inhibitors

Rainer Soyka; Armin Heckel; Josef Nickl; Wolfgang Prof Dr Eisert; Thomas Mueller; Hans Weisenberger


Archive | 2004

Method for the production of amino crotonyl compounds

Werner Rall; Rainer Soyka; Christian Kulinna; Juergen Schnaubelt; Peter Sieger


Archive | 2003

Powdered medicaments containing a tiotropium salt and salmeterol xinafoate

Mareke Hartig; Michael Trunk; Rainer Soyka; Peter Sieger; Hagen Graebner; Michael Walz


Archive | 2006

Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof

Frank Himmelsbach; Marco Santagostino; Birgit Jung; Rainer Soyka


Archive | 2003

Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate

Hagen Graebner; Mareke Hartig-Heimel; Peter Sieger; Rainer Soyka; Michael Trunk; Michael Walz

Collaboration


Dive into the Rainer Soyka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge